GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

未开盘 01-09 16:00:00 EST

0.6770

-0.0030

-0.44%

盘后0.6886

+0.0116+1.71%

19:57 EST

最高0.6900	最低0.6100	成交量159.81万
今开0.6730	昨收0.6800	日振幅11.76%
总市值720.07万	流通市值627.07万	总股本1,064万
成交额104.66万	换手率17.25%	流通股本926.25万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":0.677,"timestamp":1767992400000,"preClose":0.68,"halted":0,"volume":1598080,"hourTrading":{"tag":"盘后","latestPrice":0.6886,"preClose":0.677,"latestTime":"19:57 EST","volume":9697,"amount":6569.88678,"timestamp":1768006638602},"delay":0,"floatShares":9262500,"shares":10636135,"eps":-3.3776,"marketStatus":"未开盘","change":-0.003,"latestTime":"01-09 16:00:00 EST","open":0.673,"high":0.69,"low":0.61,"amount":1046645.236736,"amplitude":0.117647,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.3776,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.68,"preHourTrading":{"tag":"盘前","latestPrice":0.69,"preClose":0.68,"latestTime":"09:23 EST","volume":3182,"amount":2172.469293,"timestamp":1767968603644},"postHourTrading":{"tag":"盘后","latestPrice":0.6886,"preClose":0.677,"latestTime":"19:57 EST","volume":9697,"amount":6569.88678,"timestamp":1768006638602},"volumeRatio":1.1110276839685351,"impliedVol":2.3584,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GTBP","defaultTab":"news","newsList":[{"id":"1171041667","title":"GT Biopharma Inc.截至9月30日持有260万美元现金及现金等价物，资金运营覆盖至2026年第一季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1171041667","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171041667?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:09","pubTimestamp":1763129359,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc.截至9月30日持有260万美元现金及现金等价物，资金运营覆盖至2026年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"1179320283","title":"GT Biopharma Inc.: 预计将在2025年12月底或2026年1月递交Gtb-5550的IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1179320283","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179320283?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:09","pubTimestamp":1763129356,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc.: 预计将在2025年12月底或2026年1月递交Gtb-5550的IND申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"1141227084","title":"GT Biopharma发布Gtb-3650 I期临床试验参与者招募更新，针对复发性或难治性CD33表达血液系统恶性肿瘤患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1141227084","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141227084?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:01","pubTimestamp":1761224479,"startTime":"0","endTime":"0","summary":"GT Biopharma发布Gtb-3650 I期临床试验参与者招募更新，针对复发性或难治性CD33表达血液系统恶性肿瘤患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2577237554","title":"Gt Biopharma, Inc.盘中异动 临近收盘股价大跌5.39%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577237554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577237554?lang=zh_cn&edition=full","pubTime":"2025-10-23 03:59","pubTimestamp":1761163176,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日03时59分，Gt Biopharma, Inc.股票出现波动，股价急速下跌5.39%。截至发稿，该股报0.662美元/股，成交量50.0898万股，换手率14.08%，振幅7.15%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023035936973d1506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023035936973d1506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2575488047","title":"Gt Biopharma, Inc.盘中异动 大幅下挫5.56%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575488047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575488047?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:20","pubTimestamp":1760538027,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日22时20分，Gt Biopharma, Inc.股票出现波动，股价快速跳水5.56%。截至发稿，该股报0.680美元/股，成交量22.8637万股，换手率6.43%，振幅2.79%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015222028a6baf9da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015222028a6baf9da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2575252713","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575252713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575252713?lang=zh_cn&edition=full","pubTime":"2025-10-13 23:40","pubTimestamp":1760370021,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日23时40分，Gt Biopharma, Inc.股票出现波动，股价快速拉升5.90%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013234022972b876f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013234022972b876f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"1106596336","title":"GT Biopharma公布Gtb-3650一期临床试验入组更新，试验针对复发或难治性CD33阳性血液恶性肿瘤患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1106596336","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106596336?lang=zh_cn&edition=full","pubTime":"2025-10-08 21:02","pubTimestamp":1759928523,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc.近日发布了其Gtb-3650一期临床试验的入组进展更新。该试验专门针对患有复发或难治性CD33表达血液恶性肿瘤的患者群体。\n此次试验更新显示了公司在血液肿瘤治疗领域的持续推进，为那些对传统治疗方案产生抗药性或疾病复发的患者提供新的治疗选择。CD33是一种在某些血液癌症细胞表面表达的蛋白质，成为靶向治疗的重要标靶。\nGT Biopharma通过这一试验更新，展现了其在开发创新癌症疗法方面的进展，特别是针对难治性血液系统恶性疾病的治疗突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2570854428","title":"Gt Biopharma, Inc.盘中异动 下午盘快速拉升6.43%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570854428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570854428?lang=zh_cn&edition=full","pubTime":"2025-09-27 02:12","pubTimestamp":1758910334,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日02时12分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升6.43%。截至发稿，该股报0.810美元/股，成交量19.0176万股，换手率5.35%，振幅7.10%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927021215a6a0a359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927021215a6a0a359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2566225649","title":"Gt Biopharma, Inc.盘中异动 股价大跌18.75%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566225649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566225649?lang=zh_cn&edition=full","pubTime":"2025-09-11 21:32","pubTimestamp":1757597576,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日21时32分，Gt Biopharma, Inc.股票出现波动，股价急速下挫18.75%。截至发稿，该股报0.650美元/股，成交量21.947万股，换手率6.17%，振幅18.75%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213256a4c11cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213256a4c11cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2557059917","title":"Gt Biopharma, Inc.盘中异动 临近收盘大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557059917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557059917?lang=zh_cn&edition=full","pubTime":"2025-08-08 04:00","pubTimestamp":1754596826,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日04时00分，Gt Biopharma, Inc.股票出现异动，股价急速拉升5.17%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808040026973a4162&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808040026973a4162&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2555883953","title":"Gt Biopharma, Inc.盘中异动 早盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555883953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555883953?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:55","pubTimestamp":1753970147,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时55分，Gt Biopharma, Inc.股票出现异动，股价急速跳水5.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为2.16%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215548972a5a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215548972a5a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2555870679","title":"Gt Biopharma, Inc.盘中异动 临近收盘急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555870679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555870679?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:39","pubTimestamp":1753731591,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时39分，Gt Biopharma, Inc.股票出现波动，股价急速拉升5.10%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729033952a468300c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729033952a468300c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2552178465","title":"Gt Biopharma, Inc.盘中异动 临近收盘大幅上涨5.50%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552178465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552178465?lang=zh_cn&edition=full","pubTime":"2025-07-17 03:56","pubTimestamp":1752695774,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时56分，Gt Biopharma, Inc.股票出现异动，股价大幅拉升5.50%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717035614a44f4f59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717035614a44f4f59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2551196522","title":"Gt Biopharma, Inc.盘中异动 临近午盘股价大跌6.54%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551196522?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:58","pubTimestamp":1752595087,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时58分，Gt Biopharma, Inc.股票出现异动，股价快速下挫6.54%。截至发稿，该股报2.00美元/股，成交量6.9911万股，换手率2.14%，振幅4.67%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715235807a44cc504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715235807a44cc504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2550627006","title":"Gt Biopharma, Inc.盘中异动 急速上涨5.63%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550627006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550627006?lang=zh_cn&edition=full","pubTime":"2025-07-11 00:58","pubTimestamp":1752166686,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日00时58分，Gt Biopharma, Inc.股票出现波动，股价急速拉升5.63%。截至发稿，该股报2.25美元/股，成交量5.0626万股，换手率1.55%，振幅4.69%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711005806a6a203ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711005806a6a203ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2550655045","title":"Gt Biopharma, Inc.盘中异动 早盘急速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550655045?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:07","pubTimestamp":1752070072,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时07分，Gt Biopharma, Inc.股票出现异动，股价大幅拉升5.37%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220752a440898f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220752a440898f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2549284165","title":"Gt Biopharma, Inc.盘中异动 早盘大幅下挫5.53%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549284165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549284165?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:33","pubTimestamp":1751981618,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时33分，Gt Biopharma, Inc.股票出现异动，股价快速下跌5.53%。截至发稿，该股报2.05美元/股，成交量1.5879万股，换手率0.49%，振幅2.76%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213338a43e3199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213338a43e3199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2549558881","title":"Gt Biopharma, Inc.盘中异动 早盘快速下挫5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558881?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895188,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分，Gt Biopharma, Inc.股票出现异动，股价急速跳水5.55%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721330895399d43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721330895399d43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2548887830","title":"Gt Biopharma, Inc.盘中异动 临近收盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548887830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548887830?lang=zh_cn&edition=full","pubTime":"2025-07-02 04:16","pubTimestamp":1751400984,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日04时16分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫5.03%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702041624a728fc0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702041624a728fc0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2546895741","title":"Gt Biopharma, Inc.盘中异动 大幅跳水5.26%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546895741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546895741?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:41","pubTimestamp":1751031675,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日21时41分，Gt Biopharma, Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报3.60美元/股，成交量7485股，换手率0.24%，振幅5.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627214116952e2e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627214116952e2e46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1715},{"period":"1month","weight":0.0067},{"period":"3month","weight":-0.0043},{"period":"6month","weight":-0.6964},{"period":"1year","weight":-0.7345},{"period":"ytd","weight":-0.1378}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于专有的三特异性杀手接合器融合蛋白免疫细胞接合器技术平台的新型免疫肿瘤产品的开发和商业化。TriKE可设计用于针对血液恶性肿瘤或实体肿瘤的任何数量的肿瘤抗原，不需要患者特异性定制。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041835},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.141386},{"month":3,"riseRate":0.428571,"avgChangeRate":0.037703},{"month":4,"riseRate":0.428571,"avgChangeRate":0.030127},{"month":5,"riseRate":0.625,"avgChangeRate":0.082319},{"month":6,"riseRate":0.5,"avgChangeRate":0.017541},{"month":7,"riseRate":0.25,"avgChangeRate":-0.059541},{"month":8,"riseRate":0.125,"avgChangeRate":-0.133669},{"month":9,"riseRate":0.125,"avgChangeRate":-0.164268},{"month":10,"riseRate":0.75,"avgChangeRate":0.054196},{"month":11,"riseRate":0.125,"avgChangeRate":-0.132411},{"month":12,"riseRate":0.375,"avgChangeRate":0.036951}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}